glp 16&1 GLP1-Injections USP provides resources to ensure
Description
Microneedle systems may eventually solve part of this problem
Biochem Biophys Res Commun 2016;476:196-203.ArticlePubMed 34
Key Takeaways North America led the GLP-1 market by holding a major share of 57% in 2025
Oral semaglutide ($249/month) and oral tirzepatide ($279/month) may feel gentler on the GI tract than injections because they bypass initial rapid systemic absorption, though oral bioavailability is lower and requires strict fasting administration
aRR, adjusted relative risk
